READ MORE..U.S. NATIONAL INSTITUTES OF HEALTH

READ MORE: "For the first time, an experimental drug has been shown to curb both forms of brain lesions found in Alzheimer's disease -- at least in mice.The compound, called AF267B, shut down both the amyloid protein plaques that collect in Alzheimer's-affected brains, as well as another lesion, the 'tangles' of protein called tau.What's more, AF267B also appeared to reverse cognitive declines in mice genetically designed to mimic Alzheimer's disease."

Read More | Reuters.co.uk: "Depression is one of the most common health disorders in the US, and heart disease is a leading cause of death. 'Although they can and do occur separately, research shows that the two conditions are often connected,' health experts write in the February issue of the Mayo Clinic Women's HealthSource. Previous studies have shown that depression is more common among people with heart disease than among those without. Researchers found that one in three heart attack survivors experience depression, compared to about one in 20 adults in the general population. Depression has also been shown to be a precursor to heart disease. "

This tour explains how the brain works and how Alzheimer's affects it.CLICK FOR TOUR

READ MORE - New York Times: "Genentech and Biogen Idec won federal approval yesterday to sell their cancer drug Rituxan as a treatment for rheumatoid arthritis."

CNNCNN...READ MORE: "The next big stroke drug could come from the venomous mouth of a viper.Neurobiological Technologies, a California-based biotech, is milking the fangs of Malayan pit vipers at its Kentucky snake farm. Extracting snake venom by hand is not for the squeamish, but it could yield a drug that prevents brain damage in stroke victims......MORE"